CD4+ CD25+ regulatory T cells partially mediate the beneficial effects of FTY720, a sphingosine-1-phosphate analogue, during ischaemia/reperfusion-induced acute kidney injury

Nephrology Dialysis Transplantation

Volumn 26, Issue 1, 2011, Pages 111-124

  Kim, Myung Gyu ^a   Lee, So Young ^b   Ko, Yoon Sook ^a   Lee, Hee Young ^a   Jo, Sang Kyung ^a   Cho, Won Yong ^a   Kim, Hyoung Kyu ^a  

^a Korea University College of Medicine   (South Korea)

^b Eulji General Hospital   (South Korea)

Author keywords

acute kidney injury; dendritic cell; FTY720; regulatory T lymphocyte

Indexed keywords

CD11B ANTIGEN; FINGOLIMOD; GLYCOPROTEIN P 15095; MESSENGER RNA; SPHINGOSINE 1 PHOSPHATE; TRANSCRIPTION FACTOR FOXP3;

ACUTE KIDNEY FAILURE; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; DRUG MECHANISM; FLOW CYTOMETRY; KIDNEY ISCHEMIA; LYMPHOCYTOPENIA; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REPERFUSION INJURY;

ACUTE KIDNEY INJURY; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KIDNEY; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOPENIA; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, INBRED C57BL; PROPYLENE GLYCOLS; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPHINGOSINE; SPLEEN; T-LYMPHOCYTES, REGULATORY;

EID: 78650674133     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq480     Document Type: Article

References (33)

1. Awad AS, Ye H, Huang L et al. Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 2006; 290: F1516-1524
2. Delbridge MS, Shrestha BM, Raftery AT et al. Reduction of ische-mia-reperfusion injury in the rat kidney by FTY720, a synthetic derivative of sphingosine. Transplantation 2007; 84: 187-195
3. Bajwa A, Jo SK, Ye H et al. Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury. J Am Soc Nephrol 2010; 21: 955-965
4. Lan YY, De Creus A, Colvin BL et al. The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo. Am J Transplant 2005; 5: 2649-2659
5. Muller H, Hofer S, Kaneider N et al. The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells. Eur J Immunol 2005; 35: 533-545
6. Sawicka E, Dubois G, Jarai G et al. The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity. J Immunol 2005; 175: 7973-7980
7. Idzko M, Hammad H, van Nimwegen M et al. Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J Clin Invest 2006; 116: 2935-2944
8. Daniel C, Sartory N, Zahn N et al. FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+ CD25+ regulatory T cells. J Immunol 2007; 178: 2458-2468
9. Sehrawat S, Rouse BT. Anti-inflammatory effects of FTY720 against viral-induced immunopathology: role of drug-induced conversion of T cells to become FoxP3+ regulators. J Immunol 2008; 180: 7636-7647
10. Kinsey GR, Sharma R, Huang L et al. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 2009; 20: 1744-1753
11. Gandolfo MT, Jang HR, Bagnasco SM et al. FoxP3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int 2009; 76: 717-729
12. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol 2008; 109: e102-107
13. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996; 334: 1448-1460
14. Wu H, Chen G, Wyburn KR et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 2007; 117: 2847-2859
15. Li L, Huang L, Sung SS et al. NKT cell activation mediates neu-trophil IFN-gamma production and renal ischemia-reperfusion injury. J Immunol 2007; 178: 5899-5911
16. Kelly KJ, Williams WWJr, Colvin RB et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996; 97: 1056-1063
17. Day YJ, Huang L, Ye H et al. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macro-phages. Am J Physiol Renal Physiol 2005; 288: F722-731
18. Oh DJ, Dursun B, He Z et al. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice. Am J Physiol Renal Physiol 2008; 294: F264-271
19. Burne MJ, Daniels F, El Ghandour A et al. Identification of the CD4 (+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 2001; 108: 1283-1290
20. Ysebaert DK, De Greef KE, De Beuf A et al. T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 2004; 66: 491-496
21. Matsuura M, Imayoshi T, Okumoto T. Effect of FTY720, a novel im-munosuppressant, on adjuvant- and collagen-induced arthritis in rats. Int J Immunopharmacol 2000; 22: 323-331
22. Budde K, Schmouder RL, Brunkhorst R et al. First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients. J Am Soc Nephrol 2002; 13: 1073-1083
23. Kimura T, Hasegawa T, Nakai H et al. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells. Transplantation 2003; 75: 1469-1474
24. Kataoka H, Sugahara K, Shimano K et al. FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration. Cell Mol Immunol 2005; 2: 439-448
25. Kohno T, Tsuji T, Hirayama K et al. A novel immunomodulator, FTY720, prevents development of experimental autoimmune myas-thenia gravis in C57BL/6 mice. Biol Pharm Bull 2005; 28: 736-739
26. Zhou PJ, Wang H, Shi GH et al. Immunomodulatory drug FTY720 induces regulatory CD4(+)CD25(+) T cells in vitro. Clin Exp Immunol 2009; 157: 40-47
27. Huber S, Schramm C, Lehr HA et al. Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol 2004; 173: 6526-6531
28. ChenW,JinW,HardegenNetal. Conversionofperipheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor FoxP3. J Exp Med 2003; 198: 1875-1886
29. Radeke HH, von Wenckstern H, Stoidtner K et al. Overlapping signaling pathways of sphingosine 1-phosphate and TGF-beta in the murine Langerhans cell line XS52. J Immunol 2005; 174: 2778-2786
30. Xin C, Ren S, Eberhardt Wet al. The immunomodulator FTY720 and its phosphorylated derivative activate the Smad signalling cascade and upregulate connective tissue growth factor and collagen type IV expression in renal mesangial cells. Br J Pharmacol 2006; 147: 164-174
31. Constabel H, Stankov MV, Hartwig C et al. Impaired lung dendritic cell migration and T cell stimulation induced by immunostimulatory oligonucleotides contribute to reduced allergic airway inflammation. J Immunol 2009; 183: 3443-3453
32. Loi P, Paulart F, Pajak B et al. The fate of dendritic cells in a mouse model of liver ischemia/reperfusion injury. Transplant Proc 2004; 36: 1275-1279
33. Kim MG, Boo CS, Ko YS et al. Depletion of kidney CD11c+ F4/ 80+ cells impairs the recovery process in ischaemia/reperfusion- induced acute kidney injury. Nephrol Dial Transplant 2010; 25: 2908-2921